Ascentage Pharma Group International (HKG:6855)
Hong Kong
· Delayed Price · Currency is HKD 44.76
-1.18 (-2.57%)
Apr 29, 2026, 4:08 PM HKT
HKG:6855 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | -405.43 | -925.64 | -882.92 | -782.42 | Upgrade
|
| Depreciation & Amortization | - | 91.07 | 90.81 | 60.92 | 27.53 | Upgrade
|
| Other Amortization | - | 2.1 | 2.39 | 2 | 0.8 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.04 | -0 | -2.27 | 0.03 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 0.83 | 0.7 | 9.77 | 20.89 | Upgrade
|
| Loss (Gain) on Equity Investments | - | 0.28 | -1.08 | 0.28 | - | Upgrade
|
| Stock-Based Compensation | - | 20.92 | 31.5 | 22.11 | 46.97 | Upgrade
|
| Other Operating Activities | - | 67.94 | 84.39 | 31.81 | -108.13 | Upgrade
|
| Change in Accounts Receivable | - | 62.75 | -91.54 | -0.39 | -53.97 | Upgrade
|
| Change in Inventory | - | 9.57 | -6.72 | -5.52 | -3.93 | Upgrade
|
| Change in Accounts Payable | - | 19.52 | -23.11 | 24.7 | 47.5 | Upgrade
|
| Change in Unearned Revenue | - | 4.09 | 82.98 | -24.66 | 227.39 | Upgrade
|
| Change in Other Net Operating Assets | - | 15.04 | 29.24 | 110.28 | -17.01 | Upgrade
|
| Operating Cash Flow | - | -111.36 | -726.08 | -653.92 | -604.68 | Upgrade
|
| Capital Expenditures | - | -24.29 | -46.11 | -203.29 | -435.42 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.01 | 2.35 | 0.34 | Upgrade
|
| Cash Acquisitions | - | -9.52 | -20 | -20 | -20 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -10.74 | -33.68 | -1.21 | Upgrade
|
| Investment in Securities | - | -328.23 | 98.75 | -130 | -10.23 | Upgrade
|
| Investing Cash Flow | - | -362.04 | 21.92 | -384.61 | -466.52 | Upgrade
|
| Long-Term Debt Issued | - | 535.92 | 953.5 | 763.62 | 599.74 | Upgrade
|
| Long-Term Debt Repaid | - | -681.26 | -966.86 | -67.74 | -60.24 | Upgrade
|
| Net Debt Issued (Repaid) | - | -145.34 | -13.36 | 695.87 | 539.5 | Upgrade
|
| Issuance of Common Stock | - | 533.95 | 470.09 | 0.02 | 1,197 | Upgrade
|
| Repurchase of Common Stock | - | - | -5.92 | -26.78 | -25.87 | Upgrade
|
| Other Financing Activities | - | -73.84 | -82.06 | -49.85 | 70.97 | Upgrade
|
| Financing Cash Flow | - | 314.77 | 368.75 | 619.27 | 1,781 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 13.68 | 27.81 | 58.01 | -23.28 | Upgrade
|
| Net Cash Flow | - | -144.95 | -307.59 | -361.25 | 686.91 | Upgrade
|
| Free Cash Flow | - | -135.65 | -772.19 | -857.2 | -1,040 | Upgrade
|
| Free Cash Flow Margin | - | -13.83% | -347.86% | -408.75% | -3726.60% | Upgrade
|
| Free Cash Flow Per Share | - | -0.45 | -2.73 | -3.25 | -4.08 | Upgrade
|
| Cash Interest Paid | - | 60.56 | 92.35 | 49.85 | 16.81 | Upgrade
|
| Cash Income Tax Paid | - | - | - | - | 3.85 | Upgrade
|
| Levered Free Cash Flow | - | -81.25 | -706.12 | -680.98 | -954.65 | Upgrade
|
| Unlevered Free Cash Flow | - | -40.96 | -646.09 | -647.99 | -944.19 | Upgrade
|
| Change in Working Capital | - | 110.97 | -9.15 | 104.41 | 189.65 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.